Works matching IS 09024441 AND DT 2021 AND VI 107 AND IP 5
Results: 9
Pre‐transplant minimal residual disease assessment and transplant‐related factors predict the outcome of acute myeloid leukemia patients undergoing allogeneic stem cell transplantation.
- Published in:
- European Journal of Haematology, 2021, v. 107, n. 5, p. 573, doi. 10.1111/ejh.13694
- By:
- Publication type:
- Article
Safety of outpatient stem cell mobilization with low‐ or intermediate‐dose cyclophosphamide in newly diagnosed multiple myeloma patients.
- Published in:
- European Journal of Haematology, 2021, v. 107, n. 5, p. 566, doi. 10.1111/ejh.13693
- By:
- Publication type:
- Article
Involvement of G‐CSF, IL‐6, and cortisol in transient neutrophilia after marathon races.
- Published in:
- European Journal of Haematology, 2021, v. 107, n. 5, p. 583, doi. 10.1111/ejh.13695
- By:
- Publication type:
- Article
Lymphoid malignancy in common variable immunodeficiency in a single‐center cohort.
- Published in:
- European Journal of Haematology, 2021, v. 107, n. 5, p. 503, doi. 10.1111/ejh.13687
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- European Journal of Haematology, 2021, v. 107, n. 5, p. 501, doi. 10.1111/ejh.13451
- Publication type:
- Article
Post‐transplant maintenance therapy in patients with FLT3‐mutated acute myeloid leukemia: Real‐world treatment patterns and outcomes.
- Published in:
- European Journal of Haematology, 2021, v. 107, n. 5, p. 553, doi. 10.1111/ejh.13692
- By:
- Publication type:
- Article
Long‐term outcome in patients with follicular lymphoma following high‐dose therapy and autologous stem cell transplantation.
- Published in:
- European Journal of Haematology, 2021, v. 107, n. 5, p. 543, doi. 10.1111/ejh.13691
- By:
- Publication type:
- Article
Full or intensity‐reduced high‐dose melphalan and single or double autologous stem cell transplant with or without bortezomib consolidation in patients with newly diagnosed multiple myeloma.
- Published in:
- European Journal of Haematology, 2021, v. 107, n. 5, p. 529, doi. 10.1111/ejh.13690
- By:
- Publication type:
- Article
Effect of pre‐transplant JAK1/2 inhibitors and CD34 dose on transplant outcomes in myelofibrosis.
- Published in:
- European Journal of Haematology, 2021, v. 107, n. 5, p. 517, doi. 10.1111/ejh.13689
- By:
- Publication type:
- Article